Abstract
Advanced glycation end products (AGE) are independently associated with the development of atherosclerosis. AGE reduce cholesterol efflux from macrophages and enhance the uptake of LDL, leading to lipid accumulation in these cells. Furthermore, AGE stimulate both angiotesinogen and angiotensin II receptor (AT-1) expression and share, together with AT-1, intracellular signalling pathways …